Navigation Links
Bode Technology Announces Comprehensive COVID-19 Testing Program
Date:7/10/2020

Bode Technology, a leading provider of laboratory testing services and products, announces a significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES. Bode-CARES combines high-volume clinical testing with robust collection for agencies implementing testing programs.

Bode-CARES provides a turnkey solution that includes a comprehensive collection and virus-management program for our clients. Bode can offer deployed services to our client’s locations including oversight, documentation, specimen collection, transport, testing and reporting. The program includes partnerships with a national network of service providers and Bode’s core laboratory expertise.

“Bode has been involved in deploying laboratory operations across the world in challenging environments for many years,” said Mike Cariola, President and CEO. “Our team of more than 150 scientists are thankful to be able to offer this expertise to support our mission of public safety during this global pandemic.”

Bode began offering COVID-19 testing to agencies concerned with the safety and welfare of their population, including law enforcement, crime laboratories, nursing homes, and universities. As many of these organizations seek solutions to safely operate, a partnership with Bode can offer a testing solution that meets their needs.

“Quality testing and improving public safety are at our core. For 25 years now, we have used our technology to adapt to almost any situation,” said Erin Sweeney, Vice President of Operations. “Flexibility in the current environment is critical, and Bode’s expertise enables us to quickly react to the needs of our clients.”

Bode-CARES provides diagnostic tests for the SARS-CoV-2 virus. The test will indicate whether SARS-CoV-2 virus was detected in a specimen, was not detected, or was inconclusive for detection. The Bode-CARES program provides fast testing in support of our clients to ensure safer environments for the organizations and communities we serve. Through Bode’s COVID-19 testing, agencies will quickly know if an exposure, or potential exposure, to coronavirus has resulted in the detection of the SARS-CoV-2 virus.

About Bode Technology

Bode operates one of the most internationally respected private DNA laboratories and provides a comprehensive set of state-of-the-art forensic DNA collection products, DNA analysis services, and research services around the world. Bode’s laboratory is CLIA certified by the Centers for Medicare & Medicaid Services (CMS) for the purpose of providing diagnostic testing. Bode is also accredited by ANSI National Accreditation Board (ANAB) to ISO/IEC 17025:2017 for Forensic Testing and Calibration Laboratories as well as the FBI Quality Assurance Standards for Forensic DNA Testing Laboratories and DNA Databasing Laboratories. In addition, Bode is AABB certified for relationship testing and has been certified by many states that required individual certifications including Texas, New York and Maryland.

Read the full story at https://www.prweb.com/releases/bode_technology_announces_comprehensive_covid_19_testing_program/prweb17234533.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Verdad Media’s Unique MANIS Technology Means Better Reputation Management Results for Clients
3. Greenphires ClinCard Technology Platform selected by Bavarian Nordic for Major Vaccine Trial
4. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
5. Annual Conference about Technology Solutions for People with Disabilities Announces Program
6. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
7. GIN Introduces Advanced Robotics and Dispensing Technology at BVS La Jolla Biotech Day
8. The BioVoyage Institute Now Offering Hands-On Training Programs For Biotechnology Products & Applications
9. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
10. No Majority in Favor of Banning Key Crop Protection Technology
11. InSoCal CONNECT Hires Technology Talent Executive Carol Caldwell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2020)... ... August 11, 2020 , ... ... expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), ... The network is a consortium of academic research centers in the United States ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Corrigan, President and CEO has been named one of the 100 most inspiring ... sectors, PharmaVoice 100 honorees are selected based on how they have inspired their ...
(Date:7/31/2020)... ... 29, 2020 , ... Diversified Technologies, Inc. has introduced a ... to drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... a push-pull configuration; yielding fast fall time for a capacitive load. These all ...
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
Breaking Biology Technology:
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While the ... economic downturn will only increase price pressures overall for the industry. The era of ... every product launch is critical. However, history shows that only a third of product ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler ... (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... and software-driven clinical data services that accelerate drug development, is collaborating with Karyopharm ... XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first study ...
Breaking Biology News(10 mins):